Northwest Biotherapeutics Inc (NWBO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Northwest Biotherapeutics Inc (NWBO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7369
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer. The company by utilizing its proprietary technology platform, DCVax, developed a robust pipeline of therapeutic product candidates. DCVax is a personalized immune therapy and consists of therapeutic vaccine which uses patient’s own dendritic cells as the therapeutic agent. The product has two components, namely, dendritic cells (immune cells) and antigens (cancer biomarkers). The company’s product lines include DCVax-L, for the treatment of glioblastoma multiforme (GBM) brain cancer and metastatic ovarian cancer; DCVax-Direct, for the treatment of all inoperable solid tumor cancers; and DCVax-Prostate, for the treatment of late stage prostate cancer. NW Bio is headquartered in Bethesda, Maryland, the US.

Northwest Biotherapeutics Inc (NWBO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Northwest Biotherapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Northwest Biotherapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Northwest Biotherapeutics Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Northwest Biotherapeutics Raises Funds through Private Placement 10
Northwest Biotherapeutics Raises USD7.5 Million in Private Placement of Shares and Warrants 11
Northwest Biotherapeutics to Raise USD10 Million in Private Placement of Shares and Warrants 13
Northwest Biotherapeutics to Raise USD5.3 Million in Private Placement of Shares 14
Northwest Biotherapeutics to Raise USD30 Million in Private Placement of Shares 15
Northwest Biotherapeutics Raises USD25 Million in Private Placement of Shares 16
Northwest Biotherapeutics Completes Public Offering Of Units For US$27 Million 17
Northwest Biotherapeutics Inc – Key Competitors 18
Northwest Biotherapeutics Inc – Key Employees 19
Northwest Biotherapeutics Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Legal and Regulatory 21
Oct 25, 2017: NW Bio Reports Favorable Results and Progress In Resolving Lawsuits 21
Other Significant Developments 23
Oct 17, 2017: NW Bio Leases Out Warehouse On UK Property to Major Commodities Distribution Firm 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Northwest Biotherapeutics Inc, Medical Equipment, Key Facts, 2017 2
Northwest Biotherapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Northwest Biotherapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Northwest Biotherapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Northwest Biotherapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Northwest Biotherapeutics Raises Funds through Private Placement 10
Northwest Biotherapeutics Raises USD7.5 Million in Private Placement of Shares and Warrants 11
Northwest Biotherapeutics to Raise USD10 Million in Private Placement of Shares and Warrants 13
Northwest Biotherapeutics to Raise USD5.3 Million in Private Placement of Shares 14
Northwest Biotherapeutics to Raise USD30 Million in Private Placement of Shares 15
Northwest Biotherapeutics Raises USD25 Million in Private Placement of Shares 16
Northwest Biotherapeutics Completes Public Offering Of Units For US$27 Million 17
Northwest Biotherapeutics Inc, Key Competitors 18
Northwest Biotherapeutics Inc, Key Employees 19
Northwest Biotherapeutics Inc, Subsidiaries 20

List of Figures
Northwest Biotherapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Northwest Biotherapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Northwest Biotherapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Northwest Biotherapeutics Inc (NWBO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amathus Public Ltd:企業の戦略・SWOT・財務情報
    Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report Summary Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pakistan State Oil Co Ltd (PSO):企業の財務・戦略的SWOT分析
    Pakistan State Oil Co Ltd (PSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Perenco Holdings:企業の戦略的SWOT分析
    Perenco Holdings - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • OMRON Corporation:企業の戦略・SWOT・財務情報
    OMRON Corporation - Strategy, SWOT and Corporate Finance Report Summary OMRON Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Townsquare Media, Inc.:企業のM&A・事業提携・投資動向
    Townsquare Media, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Townsquare Media, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Eastman Chemical Co (EMN):企業の財務・戦略的SWOT分析
    Eastman Chemical Co (EMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Rentokil Initial plc (RTO):企業の財務・戦略的SWOT分析
    Rentokil Initial plc (RTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • The J.M. Smucker Co:戦略・SWOT・企業財務分析
    The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report Summary The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Merck & Co., Inc.:企業のM&A・事業提携・投資動向
    Merck & Co., Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merck & Co., Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • ING Groep NV:戦略・SWOT・企業財務分析
    ING Groep NV - Strategy, SWOT and Corporate Finance Report Summary ING Groep NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sistema JSFC:企業の戦略・SWOT・財務分析
    Sistema JSFC - Strategy, SWOT and Corporate Finance Report Summary Sistema JSFC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Axel Springer SE:企業の戦略・SWOT・財務情報
    Axel Springer SE - Strategy, SWOT and Corporate Finance Report Summary Axel Springer SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Taiflex Scientific Co., Ltd. (8039):企業の財務・戦略的SWOT分析
    Taiflex Scientific Co., Ltd. (8039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Clariant Chemicals (India) Limited (CLNINDIA):企業の財務・戦略的SWOT分析
    Clariant Chemicals (India) Limited (CLNINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Active Biotech AB (ACTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Active Biotech AB (Active Biotech) is a biotechnology company that develops and commercializes pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company’s key products in development include Laquinimod (neurodegenerative diseases); Anyara (cancer); Tasqu …
  • Duke Energy Ohio Inc:企業の戦略的SWOT分析
    Duke Energy Ohio Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Phoenix Children’s Hospital-医療機器分野:企業M&A・提携分析
    Summary Phoenix Children's Hospital (PCH) is a healthcare center that provides medical services. The center’s services include anestesiology, dermatology, dermatology, child protection, bone marrow transplants, adolescent medicine, critical care, emergency medicine, developmental paediatrics and fet …
  • H&R GmbH & Co KGaA (2HR):企業の財務・戦略的SWOT分析
    H&R GmbH & Co KGaA (2HR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Toyota Industries Corp (6201):企業の財務・戦略的SWOT分析
    Toyota Industries Corp (6201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆